IMPAACT P1107 Press Coverage from CROI 2022

At CROI 2022, the IMPAACT P1107 protocol team reported the first known case of a woman with HIV remission following a CCR5Δ32 stem cell transplant for treatment of acute myelogenous leukemia. The study participant, a U.S. woman who identifies as mixed race, stopped antiretroviral therapy (ART) 37 months post-transplant. With the exception of transient trace levels of HIV DNA detected 14 weeks after stopping ART, no HIV has been detected for 14 months.

HIV-infected T cell, NIAID

Press Coverage as of 2/15/22